You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Biomanufacturing 3-Hydroxypropionate through Commercial-Scale Anaerobic Fermentation

    SBC: BLUESTEM BIOSCIENCES INC            Topic: C5610d

    C56-10d-273616To meet the need for more sustainable manufacturing supply chains with reduced greenhouse gas emissions and to remove reliance on foreign supply chains, policymakers and researchers have begun exploring the possibilities of biomanufacturing commodity chemicals and materials. Acrylates are a primary monomeric component in paints, coatings, plastics, and super-absorbent polymer applica ...

    SBIR Phase I 2023 Department of Energy
  2. High-resolution/high-precision PEM Quality Control

    SBC: RESONON, INC.            Topic: C5618h

    High-quality, defect free, and consistent thickness Proton Exchange Membrane (PEM) films are required to ensure maximum efficiency and longevity over the life of hydrogen fuel cells or electrolyzers utilizing this technology. The current technologies of PEM film Quality Assurance (QA) and defect detection rely on human inspection, which can be subjective and labor intensive, or measurement technol ...

    SBIR Phase I 2023 Department of Energy
  3. BEASTS-Novel Biomimetic Liver Platform for Enabling ALD Researchers

    SBC: KESHAVA BIOSCIENCES LLC            Topic: 350

    PROJECT SUMMARY Alcoholic liver disease (ALD) is one of the major causes of morbidity and mortality in the world. Significant challenges remain for developing preventive or curative approaches targeting ALD. No effective treatments for ALD currently exist but for reducing alcohol consumption or liver transplantation. The current paucity of clinically relevant experimental models impedes any effort ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Booth™ by Opio™: Developing technology to expand the reach of opioid treatment programs into rural and underserved areas.

    SBC: Opio Connect, Inc.            Topic: NIDA

    The goal of this project is to develop a treatment booth with technology that allows opioid treatment programs to remotely dispense, either methadone or buprenorphine, under medical observation through telemedicine to a patient in a treatment booth. We believe that robotic automation is the ideal application to perform the same mechanical functions of the nurse at the dosing window. Specifically, ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options

    SBC: Golden Helix, Inc.            Topic: 172

    Abstract Pharmacogenomics, the study of how an individual's genetic makeup affects their response to drugs, has undergone rapid advancements. This has occurred alongside a decrease in the cost of genotyping technology, making implementation of pharmacogenomics into clinical practice increasingly feasible. Personalized medicine leveraging pharmacogenomics is gaining momentum to optimize drug choice ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  6. XVIR-110 an ultra-long-acting INSTI for HIV pre-exposure prophylaxis in IND-enabling studies

    SBC: EXAVIR THERAPEUTICS INC.            Topic: NIAID

    PROJECT SUMMARY While there are now successful treatment regimens and prevention strategies for people living with HIV/AIDS, the HIV pandemic remains a public health crisis in the United States and worldwide, with nearly 40,000 new infections each year in the US alone. To prevent the spread of HIV in vulnerable populations, the US Preventive Services Task Force has recommended HIV pre-exposure pro ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  7. Selective CYP26 inhibitors for the oral treatment of recalcitrant nodular acne.

    SBC: DERMAXON LLC            Topic: NIAMS

    Project Summary / Abstract DermaXon's project goal is to develop efficacious, substrate-based, selective inhibitors of CYP26s, the enzymes responsible for the metabolism of all-trans retinoic acid (atRA) in the epidermis, as an oral treatment for severe recalcitrant acne. This approach will provide an improved acne therapeutic without the adverse effects associated with currently marketed retinoid ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Development of robust fully autonomous machine learning-based cloud processing for Infrared Cloud Imagers

    SBC: NWB SENSORS INC            Topic: C5326b

    Cloud cover is an important but poorly characterized component of current climate models. In particular, there is a need to detect and quantify cloud cover in a physically meaningful manner. This need has led to the development of infrared cloud imagers. This system uses long-wave infrared cameras to observe the thermal emission from the clouds and produces a measurement of spatially distributed c ...

    SBIR Phase I 2022 Department of Energy
  9. Waveguide-based squeezed light sources

    SBC: ADVR, INC.            Topic: C5305a

    Squeezed light sources are a critical component of continuous variable quantum networking and quantum computing systems. Periodically poled nonlinear optical waveguides are a promising technology for squeezed light sources due to high conversion efficiency, long interaction length, robust fiber coupling, and integration potential. While these waveguides are available commercially, they are not opt ...

    SBIR Phase I 2022 Department of Energy
  10. Commercial Production of Low-Loss Quantum Frequency Conversion and Electro-Optical Modulation Devices Enabled by Wafer-Level Processing of Reverse-Proton-Exchange Lithium Niobate Waveguides

    SBC: ADVR, INC.            Topic: C5106a

    Quantum optical networks will require all optical signal processing that is enabled by lithium niobate-based components. While many of these components are commercially available, they are not optimized for the ultra-low optical losses required for quantum applications. This program will develop refined processing techniques to fabricate ultra-low loss lithium niobate- based components, initially ...

    SBIR Phase II 2022 Department of Energy
US Flag An Official Website of the United States Government